ResMed Earnings: Solid Device Sales and EBIT Margin Expansion (Corrected)

Our prior research for the Australian CDIs had incorrect financial ratios, given a recent change in our process for extracting financial ratios from our equity databases. This has now been corrected. In future, our dividend and earnings forecasts will be shown on a USD per share basis. Each ResMed share is equivalent to 10 CDIs. The shares are traded in the US, whereas the CDIs are traded on the Australian stock exchange.